193 related articles for article (PubMed ID: 30502990)
1. Triamcinolone in small-gauge vitrectomy for epiretinal membrane peeling.
Angermann R; Zehetner C; Sidoroff P; Waltl I; Kieselbach G; Kralinger M
Can J Ophthalmol; 2018 Dec; 53(6):632-636. PubMed ID: 30502990
[TBL] [Abstract][Full Text] [Related]
2. The long-term anatomical and visual effect of intravitreal triamcinolone injection during vitrectomy for the treatment of idiopathic macular epiretinal membrane.
Lai CC; Wang NK; Wu WC; Yeung L; Hwang YS; Chen KJ; Chen TL; Chuang LH
Cutan Ocul Toxicol; 2011 Dec; 30(4):292-7. PubMed ID: 21449851
[TBL] [Abstract][Full Text] [Related]
3. Anatomic and functional outcome after 23-gauge vitrectomy, peeling, and intravitreal triamcinolone for idiopathic macular epiretinal membrane.
Konstantinidis L; Berguiga M; Beknazar E; Wolfensberger TJ
Retina; 2009 Sep; 29(8):1119-27. PubMed ID: 19734764
[TBL] [Abstract][Full Text] [Related]
4. A Comparison of Intraoperative Dexamethasone Intravitreal Implant and Triamcinolone Acetonide Used During Vitrectomy and Epiretinal Membrane Peeling: A Case Control Study.
Yonekawa Y; Mammo DA; Thomas BJ; Wolfe JD; Hassan TS
Ophthalmic Surg Lasers Imaging Retina; 2016 Mar; 47(3):232-7. PubMed ID: 26985796
[TBL] [Abstract][Full Text] [Related]
5. A prospective randomized clinical trial comparing nepafenac, intravitreal triamcinolone and no adjuvant therapy for epiretinal membrane.
Mandelcorn ED; Al-Falah M; Zhao LD; Kertes P; Devenyi R; Lam WC
Acta Ophthalmol; 2022 Feb; 100(1):e297-e303. PubMed ID: 33847066
[TBL] [Abstract][Full Text] [Related]
6. Relationship between the morphology of the foveal avascular zone and the degree of aniseikonia before and after vitrectomy in patients with unilateral epiretinal membrane.
Hirata A; Nakada H; Mine K; Masumoto M; Sato T; Hayashi K
Graefes Arch Clin Exp Ophthalmol; 2019 Mar; 257(3):507-515. PubMed ID: 30637451
[TBL] [Abstract][Full Text] [Related]
7. Effect of intravitreal triamcinolone injection during vitrectomy for idiopathic epiretinal membrane.
Ahn JH; Park HJ; Lee JE; Oum BS
Retina; 2012 May; 32(5):892-6. PubMed ID: 22252232
[TBL] [Abstract][Full Text] [Related]
8. Visual Outcomes of Pars Plana Vitrectomy with Epiretinal Membrane Peeling in Patients with Asteroid Hyalosis: A Matched Cohort Study.
Mouna A; Berrod JP; Conart JB
Ophthalmic Res; 2017; 58(1):35-39. PubMed ID: 28463846
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal bevacizumab vs intravitreal triamcinolone combined with macular laser grid for diffuse diabetic macular oedema.
Forte R; Cennamo GL; Finelli M; Farese E; D'Amico G; Nicoletti G; de Crecchio G; Cennamo G
Eye (Lond); 2010 Aug; 24(8):1325-30. PubMed ID: 20300127
[TBL] [Abstract][Full Text] [Related]
10. Relation of anatomy with function following the surgical treatment of idiopathic epiretinal membrane: a multicenter retrospective study.
Ozdek S; Ozdemir Zeydanli E; Karabas L; Teke MY; Yilmaz G; Citirik M; Kocak N; Durukan H;
Graefes Arch Clin Exp Ophthalmol; 2021 Apr; 259(4):891-904. PubMed ID: 33185727
[TBL] [Abstract][Full Text] [Related]
11. Preoperative and intraoperative prognostic factors of epiretinal membranes using chromovitrectomy and internal limiting membrane peeling.
Machado LM; Furlani BA; Navarro RM; Farah ME; Maia A; Magalhães O; Rodrigues EB; Moraes N; Maia M
Ophthalmic Surg Lasers Imaging Retina; 2015 Apr; 46(4):457-62. PubMed ID: 25932723
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal triamcinolone, bevacizumab and pegaptanib for occult choroidal neovascularization.
Forte R; Cennamo G; Finelli M; Cesarano I; D'Amico G; De Crecchio G; Cennamo G
Acta Ophthalmol; 2010 Dec; 88(8):e305-10. PubMed ID: 20946332
[TBL] [Abstract][Full Text] [Related]
13. Postoperative restoration of foveal inner retinal configuration in patients with epiretinal membrane and abnormally thick inner retina.
Yang HS; Kim JT; Joe SG; Lee JY; Yoon YH
Retina; 2015 Jan; 35(1):111-9. PubMed ID: 25102192
[TBL] [Abstract][Full Text] [Related]
14. [Intraoperative risk factors associated with visual acuity outcomes of pars plana vitrectomy in idiopathic epiretinal membrane].
Li HH; Liao X; Xie CL; Gao XR; Wang H; Wang F
Zhonghua Yan Ke Za Zhi; 2017 May; 53(5):344-351. PubMed ID: 28494562
[No Abstract] [Full Text] [Related]
15. Triamcinolone acetonide as an adjuvant to membrane peeling surgery: a pilot study.
Paspulati A; Punjabi OS; Theodoropoulou S; Singh RP
Ophthalmic Surg Lasers Imaging Retina; 2013; 44(1):41-5. PubMed ID: 23418733
[TBL] [Abstract][Full Text] [Related]
16. Vitrectomy With Epiretinal Membrane Peeling Alone Verses Combined With Internal Limiting Membrane Peeling For Idiopathic Epiretinal Membrane.
Jatoi A; Shaikh FF; Rehman AU
J Ayub Med Coll Abbottabad; 2020; 32(4):450-453. PubMed ID: 33225642
[TBL] [Abstract][Full Text] [Related]
17. Pars plana vitrectomy with internal limiting membrane peeling compared with intravitreal triamcinolone injection in the treatment of diabetic macular edema.
Kim YM; Chung EJ; Byeon SH; Lee SC; Kwon OW; Koh HJ
Ophthalmologica; 2009; 223(1):17-23. PubMed ID: 18849632
[TBL] [Abstract][Full Text] [Related]
18. Effects of repeated injection of intravitreal triamcinolone on macular oedema in central retinal vein occlusion.
Wang L; Song H
Acta Ophthalmol; 2009 May; 87(3):285-9. PubMed ID: 18507724
[TBL] [Abstract][Full Text] [Related]
19. [Clinical study of vitrectomy with epiretinal membrane peeling for idiopathic macular epiretinal membrane].
Liu Z; Ye J; Chen Y; Dong F
Zhonghua Yan Ke Za Zhi; 2016 May; 52(5):343-7. PubMed ID: 27220706
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
